Stockreport

Harness Therapeutics Announces Launch of MISBA® Duo Platform and Research Collaboration with Ono Venture Investment [Yahoo! Finance]

ONO PHARM CO UNSP/ADR  (OPHLY) 
NASDAQ:AMEX Investor Relations: ono.co.jp/eng/investor/index.html
PDF Proprietary MISBA Duo technology is the first platform to enable simultaneous, controlled upregulation and downregulation of two targets R&D programme with Ono Ventur [Read more]